Description:
Active pharmaceutical ingredients (APIs) and excipients that comprise oral solid dosage are designed to achieve controllable bioavailability of the APIs in human body and to enable robustness during product manufacturing. Particle engineering offers tools and methodologies, both experimental and numerical, to design the structure of pharmaceutical particles to achieve the desired responses. This session invites papers that highlight advances in particle design and engineering as applied to pharmaceutical systems. Papers can be experimental in nature, while fundamental theoretical or modeling works providing insight into the formation and behavior of the particles are also welcome. Both novel formulations and the manufacturing processes that yield engineered particles are of interest to this session, as well as scientific approaches that relate particle formation, structure and functional performance.
Sponsor:
Applications of Particle Technology for Pharmaceuticals
Chair:
Chi-Hwa Wang
Professor
National University of Singapore
Department of Chemical and Biomolecular Engineering
M3TC Research Center
Singapore
117576
Phone Number: +65 65165079
Fax Number: 65-67791936
Email: chewch@nus.edu.sg
Professor
National University of Singapore
Department of Chemical and Biomolecular Engineering
M3TC Research Center
Singapore
117576
Phone Number: +65 65165079
Fax Number: 65-67791936
Email: chewch@nus.edu.sg
Co-Chair:
Ecevit Bilgili
Associate Professor
New Jersey Institute of Technology
Otto H. York Department of Chemical, Biological, and Pharmaceutical Engineering
161 Warren St. 150 Tiernan Hall
Newark, NJ
07102
Phone Number: 973-596-2998
Email: bilgece@njit.edu
Associate Professor
New Jersey Institute of Technology
Otto H. York Department of Chemical, Biological, and Pharmaceutical Engineering
161 Warren St. 150 Tiernan Hall
Newark, NJ
07102
Phone Number: 973-596-2998
Email: bilgece@njit.edu
Papers:
Abstract Submissions Closed
See more of this Group/Topical: Applications of Particle Technology for Pharmaceuticals
